Generic drug
Oxycodone price, strengths & recalls
Generic of Oxycontin, Roxicodone, Roxybond
Pharmacies pay $2.77 for 30 tablets of Oxycodone 5 mg tablet this week, and from $2.77 to $67.75 across its 8 priced strengths and forms. 28 manufacturers make it. 2 recalls are ongoing. Its official label last changed on December 12, 2025.
2 open recallsGeneric- Fair cash price
- $13.69
- Strengths
- 8
- Makers
- 28
- Updated
- Nov 11
Oxycodone price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 5 mg capsule | $0.3816 | $11.45 / 30 capsules |
| 1 mg/mL oral solution | $0.0716 | $33.88 / 473 mL |
| 20 mg/mL oral solution | $2.26 | $67.75 / 30 mL |
| 5 mg tablet | $0.0924 | $2.77 / 30 tablets |
| 10 mg tablet | $0.1563 | $4.69 / 30 tablets |
| 15 mg tablet | $0.1994 | $5.98 / 30 tablets |
| 20 mg tablet | $0.2582 | $7.75 / 30 tablets |
| 30 mg tablet | $0.3612 | $10.83 / 30 tablets |
The lowest cost per tablet is 5 mg tablet at $0.0924. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of oxycodone
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 21 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Oxycodone
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use OXYCODONE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for OXYCODONE HYDROCHLORIDE ORAL SOLUTION. Oxycodone Hydrochloride oral solution CII Initial U.S. Approval: 1950
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE HYDROCHLORIDE ORAL SOLUTION
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE HYDROCHLORIDE SOLUTION
See full prescribing information for complete boxed warning.
Ensure accuracy when prescribing, dispensing, and administering Oxycodone Hydrochloride Oral Solution. Dosing errors due to confusion between mg and mL, and other oxycodone hydrochloride oral solutions of different concentrations can result in accidental overdose and death (
2.1,
5.1).
Oxycodone Hydrochloride Oral Solution exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient's risk before prescribing and reassess regularly for these behaviors and conditions (
5.2)
Serious, life-threatening, or fatal respiratory depression may occur, especially during initiation or following a dosage increase. To reduce risk of respiratory depression, proper dosing and titration of Oxycodone Hydrochloride Oral Solution are essential. (
5.3)
Accidental ingestion of Oxycodone Hydrochloride Oral Solution, especially by children, can result in a fatal overdose of oxycodone. (
5.3)
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate. (
5.4,
7)
If opioid use is required for an extended period of time in a pregnant woman, advise the patient of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery. (
5.5)
Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription. (
5.6)
The concomitant use with CYP3A4 inhibitors (or discontinuation of CYP3A4 inducers) can result in a fatal overdose of oxycodone. (
5.77,
12.3)
Risk of Medication Errors
Ensure accuracy when prescribing, dispensing, and administering Oxycodone Hydrochloride Oral Solution. Dosing errors due to confusion between mg and mL, and other oxycodone hydrochloride oral solutions of different concentrations can result in accidental overdose and death
[see
Dosage and Administration (2.1),
Warnings and Precautions (5.1)]
.
Addiction, Abuse, and Misuse
Because the use of Oxycodone Hydrochloride Oral Solution exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions
[see
Warnings and Precautions (5.2)]
.
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use of Oxycodone Hydrochloride Oral Solution, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, especially during initiation or following a dose increase. To reduce the risk of respiratory depression, proper dosing and titration of Oxycodone Hydrochloride Oral Solution are essential
[see
Warnings and Precautions (5.3)].
Accidental Ingestion
Accidental ingestion of even one dose of Oxycodone Hydrochloride Oral Solution, especially by children, can result in a fatal overdose of oxycodone
[see
Warnings and Precautions (5.3)]
.
Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of Oxycodone Hydrochloride Oral Solution and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate
[see
Warnings and Precautions (5.4),
Drug Interactions (7)].
Neonatal Opioid Withdrawal Syndrome (NOWS)
If opioid use is required for an extended period of time in a pregnant woman, advise the patient of the risk of NOWS, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery
[see
Warnings and Precautions (5.5)]
.
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription
[see
Warnings and Precautions (5.6)].
Cytochrome P450 3A4 Interaction
The concomitant use of Oxycodone Hydrochloride Oral Solution with all cytochrome P450 3A4 inhibitors may result in an increase in oxycodone plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in oxycodone plasma concentration. Regularly evaluate patients receiving Oxycodone Hydrochloride Oral Solution and any CYP3A4 inhibitor or inducer
[see
Warnings and Precautions (5.7Drug Interactions (7),
Clinical Pharmacology (12.3)].
Recent major changes (as listed on the label)
Boxed Warning | 12/2023 |
Indications and Usage (
1)
| 12/2023 |
Dosage and Administration (
2.1,
2.3,
2.4)
| 12/2023 |
Warnings and Precautions (
5.8)
| 12/2023 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA200535 · Genus Lifesciences
- First approved
- October 20, 2010 (16 years ago)
- Latest approved change
- June 18, 2026
- Approved label
- PDF, Jan 5, 2026
- Generic makers
- 20 approved generic applications on the market
Oxycodone questions
How much does oxycodone cost without insurance?
Pharmacies pay about $2.77 for 30 tablets of oxycodone 5 mg tablet ($0.0924 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $13.69. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of oxycodone?
Oxycodone is sold as Oxycontin, Roxicodone, Roxybond. The generic has the same active ingredient and usually costs far less.
Is oxycodone in shortage?
No shortage is reported for oxycodone right now. We check the national shortage list every day.
Has oxycodone been recalled?
21 recalls on record, 2 ongoing. Recalls name specific lots - check yours.
When did the oxycodone label last change?
The official label was last updated on December 12, 2025 (version 4). See what changed.
Talk about oxycodone
No comments yet. Questions, tips, what worked for you - start the conversation.